46 -Nasal epithelial transcriptome changes in response to season 47 -Pollen allergen immunotherapy (AIT) alters expression of asthma, chemokine signaling, and 48 toll like receptor signaling related genes 49 -AIT increases microbial community diversity 50 -RNA-sequencing enables integrated analysis of microbe and host transcriptomes 51 52 Capsule summary 53 Nasal epithelial transcriptome is altered by the season. Birch pollen allergen immunotherapy recovers 54 microbial community diversity and alters expression of allergy related genes. 55 56
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We also computed alpha diversities to evaluate the effect of AR and AIT on the microbial 119 diversity of nasal epithelia ( Fig E5-E7, A-N) . This analysis revealed that control subjects primarily had 120 the highest alpha diversity, differing from that seen previously in a study on seasonal allergic rhinitis 121 (4) but similar to that focusing on children with asthma and rhinitis (5). Interestingly, majority of the 122 diversity indices suggested an increase of diversity between the first and second winter in all groups. 123
Most prominent the increase was in the AR-AIT group, while some increase was also detectable in the 124 control and AR-noAIT groups (Fig E6, A-N) . The diversity at the second winter in the AR-AIT group 125 also changed more towards that of the control group than what was the corresponding change in the 126 AR-noAIT group (Fig E6, A-N) . These findings are largely in line with the previous studies noting that 127 the bacterial diversity varies during allergy season (4) and suggest that AIT may increase microbial 128 diversity and restore it towards normal. 1.4.11 1.5.11 1.6.11 1.7.11 1.8.11 1.9.11 1.10.11 1.11.11 1.12.11 1. 
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Year Finland (permission number19/13/003/00/11). Written informed consent was received from all subjects 55 and their parents if the age of the participant was under 18-years. The study has been registered in 56 ClinicalTrials.com (nro. NCT01985542) . Baseline data of the study subjects is shown in Table E1 . The 57 total number of participants entering the study was 23 ( Fig E1) . AR-AIT group received SCIT in Nov 58 2011 after the second sampling visit (Fig 1, Fig E1) , meaning that two samplings of the AR-AIT group 59 were performed before and two during AIT. 60 61 Nasal brushings and RNA extraction 62 Nasal epithelial brushing was performed to middle meatus of both sides of nasal cavity after slight 63 blowing of nose without local anesthesia as described (1). Epithelial cells were collected at four time 64 points, washed once with ice cold nuclease free PBS, and resuspended immediately into RNAlater 65 RNA stabilization reagent (Qiagen, Hilden, Germany) to preserve RNA profiles. The epithelial RNA 66 isolation was done next day using Qiagen RNeasy Mini Kit with the optional DNAse treatment 67 RNA sequencing data were preprocessed as described previously (2). Briefly, Trimmomatics (3) was 83 used to correct read data for low quality, Illumina adapters, and short read-length. Filtered paired-end 84 reads were aligned to the human genome (GRCh38) using the STAR (4) with the guidance of 85 EnsEMBL v82 gene models. Default 2-pass per-sample parameters were used, except that the overhang 86 on each side of the splice junctions was set to 99. The alignments were then sorted and PCR duplicates 87 were marked using Picard, feature counts were computed using SubRead (5), feature counts were 88 converted to expression estimates using Trimmed Mean of M-values (TMM) normalization (6), and 89 lowly expressed genomic features with counts per million (CPM) value ≤1.00 in less than half of 90 controls or birch-pollen patients were removed. Default parameters were used, with exception that 91 reads were allowed to be assigned to overlapping genome features in the feature counting. 92 93
Host gene expression analysis 94
Differential expression testing was performed using the edgeR (7) software and included testing of 95 differential expression between and within groups at different sampling points. In the statistical testing, 96 comparisons between subject groups used a combined factor of subject group and sampling point, 97 while comparisons within subject groups employed also a factor for the subject. The resulting p-values 98 were adjusted Storey's Q-value approach with significance defined as Q-value ≤0.10. A cut-off of 99 absolute log 2 fold-change of ≥ 1.5 and EnsEMBL v82 biotype annotations were used as additional 100 filters to select differentially expressed genes (DEGs) with protein coding annotation for the 101 downstream analysis. Heatmaps of differentially expressed protein coding genes were produced with 102 pheatmap R package (8). Hierarchical clusters (HC) were generated using the spearman correlation and 103 ward.D2 as the linkage method, with the exception of using ward.D2 and Euclidean distance for genes 104 that were differentially expressed between different sampling years at springs and using complete 105 linkage and spearman correlation for genes that were differentially expressed between different 106 sampling years at winters. Counts per million (CPMs) data were used to generate heatmaps. Venn 107 diagrams were generated using the VennDiagram R package (9). Functional profiles of differentially 108 expressed genes were investigated with clusterProfiler (10) using functions enrichGO and 109 enrichKEGG. Outputs of enrichment analyses were visualized using dotplot function in clusterProfiler. 110
Biologically relevant pathways found by clusterProfiler were visualized using pathview R package M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT (11). In the process, KEGG gene IDs of the selected pathways were fed along with log 2 fold-change 112 values from relevant comparisons. Color codes on the pathway map were used to illustrate genes that 113 were differentially expressed and the direction of their expression changes. Fold-change values beyond 114 that range were truncated to the closest extreme, i.e. values >2 were truncated to 2, and values < -2 115 truncated to -2. Downstream analyses were performed using R 3.3.1 with Bioconductor 3.0. 116 117
Variant analysis 118
Transcript variants were called from STAR alignments using the GATK best practices workflows for 119 transcriptome data (12) and then annotated using Annovar (13) as defined previously (2). Quality 120 control analyses were performed as defined previously (2). Variant calls were further filtered by 121 accepting only those that were present in two or more AR cases, not present in any control case, and 122 predicted to be pathogenic by various pathogen prediction methods part of the Annovar (13) annotation 123 tool. Heatmap was plotted using pheatmap. The functional effects of variants were taken from Annovar 124 (13) outputs. Additionally, we also plotted barplot using CPM expression value of genes in healthy 125 control and AR groups. 126 127
Microbial community profiling 128
Microbial community profiling was performed as previously described (14) with some modifications. 129
Specifically, RNA-sequencing data were preprocessed for adapter trimming, low quality bases filtering, 130 and removal of reads less than 36 bp in length by using Trimmomatic (3). Paired-end reads passing the 131 pre-processing were mapped against rRNA sequences from RFAM (15) v12.3 using the Burrows-132 Wheeler Aligner (BWA) (16) with default settings and reads matching rRNAs were filtered by using 133 samtools (17). Centrifuge (18) was then used to classify paired-end reads to microbial taxa. Alignment 134 data were converted to kraken-style output. In the classification, reads were aligned against 27,127 135 known complete bacterial, archaeal, and viral genome assemblies, the human genome, and 10,615 136 technical artifact sequences that were available in the RefSeq (19) database at February 2018. Default 137 parameters were used, with the exception that only one (i.e. the lowest common ancestor) assignment 138 was reported for read-pairs with multiple primary assignments. Taxa having <100 read-pairs assigned 139 to them in any sample were removed. Pairwise comparisons between and within groups at different 140 sampling points were performed by applying DeSeq2 (20) on the number of reads covered by the clade 141 rooted at the given taxon level. In the analyses, size factors were estimated by using the poscounts M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT method, comparisons between subject groups were done using a combined factor of subject group and 143 sampling point, and comparisons within subject groups with a model where individuals were nested 144 within subject groups. Each taxonomic level was analyzed separately and variance stabilizing 145 transformation (VST) was used to generate expression estimates for heatmap visualizations. The 146
Storey's Q-value adjustment (21) was used to correct data for multiple hypothesis testing, with 147 significance defined as Q-value ≤0.05. Finally, alpha diversity (Observed, Chao1, ACE, Shannon, 148
Simpson, InvSimpson, and Fisher), beta diversity (Bray-Curtis dissimilarity), and rarefaction analyses 149 were done using the Phyloseq software (22) AR subjects, and especially AR-AIT cases, had higher total median S-IgE, birch specific S-IgE, and 156 SPT wheel diameter to birch and symptom scores during samplings (Table E1 , Fig 1) . AR-AIT group 157 reported benefit (Fig 1) and reported no severe side-effects at the end of SCIT three years after start of 158 SCIT (data not shown). 159 160
Transcriptome of nasal epithelium 161
We generated in total of 5164 million raw paired-end transcript reads. Manual inspection of the quality 162 plots generated using FASTQ indicated that sequencing data was of excellent quality. On average, 90 163 million reads were mapped to the reference per subject. Mapped reads were then used to generate CPM 164 expression estimates, revealing expression of 13,873 protein coding genes among healthy controls and 165 17,347 across all the 44 samples. Altogether, expression of 34,896 genes were found. To gain insight 166 into cellular processes dysregulated in AR and AIT, differentially expressed genes between sample 167 groups were identified using edgeR (7) . In this analysis, we identified altogether 360 genes to be 168 differentially expressed with the Q-value ≤ 0.1 and absolute log 2 fold change ≥ 1.5 between different 169 timepoints within group and between different groups within timepoints. 170 171
Alterations in gene expression profiles in the two following springs and winters
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Comparison of the transcriptome profiles between the springs revealed 119 DEGs between the 173 samplings in the AR-AIT group, 49 between the samplings in the AR-noAIT group, and 27 between 174 the samplings in healthy controls (Fig 2, B) , which suggest that greatest transcriptional reprogramming 175 took place in AR-AIT group followed by AR-noAIT group and healthy subjects. Comparison of the 176 two consecutive winters revealed only 17 DEGs among healthy controls and none among AR patients, 177
suggesting that AIT alters epithelial expression only in the presence of allergens (Fig 2, E) . 178 179
Differential expression of immune response and signaling pathways 180
We performed KEGG pathway enrichment analysis to discover functional themes shared by DEGs. 181
This analysis revealed altogether 21 KEGG pathways with coordinated expression change between the 182 spring samplings (Fig 2, C) . Out of these, 4 were associated with genes differentially expressed in AR-183 AIT group, including the chemokine signaling and Toll-like receptor (TLR) signaling pathway (Fig 2, 184 C) . Genes differentially expressed in AR-noAIT group were in turn associated with 8 pathways, 185
including IL-17 signaling and asthma pathway that were discovered only in this comparison (Fig 2, C) . 186
The healthy group genes were enriched in 11 KEGG pathways (Fig 2, C) . Altogether we detected three 187 allergy related pathways, of which asthma was discovered only in the AR-noAIT comparison and TLR 188 signaling and chemokine signaling pathways were discovered in AR-noAIT and AR-AIT comparisons 189 (Fig 2, C) . Pathway enrichment analysis of winter comparison data revealed pathways with coordinated 190 expression change only in healthy controls (Fig 2, F) . 191 192
In depth analysis of allergy related pathways 193
Allergy-related pathways found in the pathway analysis ( Fig E2) were analyzed more in-depth to study 194 these mechanisms. Firstly, the asthma pathway consisted in total 3 DEGs. The AR-AIT group and 195 healthy controls displayed upregulation of MHCII and downregulation of FcεRI at the second spring 196 ( Fig E2, A) . The expression of various other members of the pathway was altered, although 197 unsignificantly, between spring samplings ( Fig E2, A) . These more borderline findings included that is a T-cell-specific transcription factor and interleukin (23), IL-4 that is IgE synthesis switch factor 199 (23), and IL-5 that is an eosinophil growth factor (23). Expression of genes of the asthma pathway 200 between timepoints occurred to opposite directions in AR-AIT and AR-noAIT groups (Fig E2, A) . The 201 second pathway of interest was TLR signaling pathway ( Fig E2, B ) consisting altogether 67 202 dysregulated genes, such as p38, TNF-α, IL-12, and INF-α genes. Expression of genes between springs 203
happened to opposite directions in AR-AIT and AR-noAIT groups (Fig E2, B) . The third pathway of 204 relevance to AR was chemokine signaling pathway. This pathway consisted of 49 dysregulated genes 205 ( Fig E2, C) , including various chemokines and chemokine receptors. Expression of genes between 206 timepoints occurred to opposite directions in AR-AIT and AR-noAIT groups (Fig E2, C) . 207 208 Transcript variants expressed in AR patients 209
The GATK best practice for RNA sequencing (12) was employed to identify expressed variants. This 210 approach revealed altogether 3,268,177 (on average 74277 per subject) variants passing GATK filters. 211
Removal of intronic and silent variants and polymorphisms resulted in 8,174 (on average 186 per 212 subject) variants that were further narrowed down to 8 potential candidates expressed in at least two 213 AR subjects at any time point but in none of the healthy control samples ( Fig E3) . 214 215
Functional characterization of microbiome showed no AR related changes 216
The effect of AR and AIT to the active nasal microbiota was studied by identifying microbial reads 217 from the RNA sequencing data and performing microbial classification. On average ~16,340 read-pairs 218 (500 CPMs) per sample were assigned to bacterial, archaeal, or viral taxa with a high sample-to-sample 219 variation (minimum of 791 reads (24 CPMs) and maximum of 69,428 reads (1791 CPMs)). Of these 220 microbial reads, on average ~98.13% were classified at genus-level and 67.08% at the species-level. 221
The genus-level classifications (Fig 2, H and Fig E4) showed that overall the most abundant genera 222
were Bacillus, Methanocaldococcus, and Alpharetrovirus, with average relative proportions of 223 ~42.23%, ~35.72%, and ~4.32%, respectively, other genera having average relative proportions of 224 ~1.57% (Acinetobacter) or less. The relative proportions of the detected genera varied greatly between 225 the samples, Bacillus demonstrating the greatest variation (relative proportions ranging from 0% to 226 ~63.76%). The relative proportions of viruses, particularly Alpharetrovirus, was greater in the second 227 spring sampling point than in the other sampling points for all the groups, whereas the relative 228 proportion of Bacillus was reduced (Fig 2, H and Fig E4, A) . This variation, however, was mainly 229 driven by the second spring samples of six cases, who were distributed among all groups (Fig E4, A) . 230
Examination of the community compositional differences between the samples revealed these six 231 samples to be the most dissimilar from the rest, which, in turn, had rather similar community 232 compositions (Fig E4, B) . To further investigate microbial richness, we estimated the alpha diversity 233 measures for all the samples (Fig E5-E7, A-N) . Majority of the indices demonstrated an increase in the M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT diversity for AR-AIT group when the second winter was compared to the first (Fig E6, A-N) . Some 235 change of diversity between second and first winters was also seen for the control group, while some 236 indices indicated also an increase for the AR-noAIT group. The increase seen in AR-noAIT group was, 237 however, less than that observed for the AR-AIT group. The second winter diversity indices of the AR-238 AIT group were also mainly closer to those of the control group than the indices of the AR-noAIT 239 group (Fig E6, A-N) . Finally, examination of significant (Q-value ≤ 0.05) changes in species 240 abundancies (Fig E4, C) revealed more changes in all groups between the two spring sampling points 241 than between the winter sampling points. The winter comparisons revealed only increased species for 242 the control and AR-AIT groups, whereas for the AR-noAIT group only decreased species were 243 reported. The AR-AIT group had significantly less Pseudomonas aeruginosa in the second spring 244 sampling point than the first. For the other groups, the comparisons revealed no significant changes in 245 the abundance of this bacterium. Timothy-specific IgE (kU/L) 0 (0-0) 0 (0-0) .85 0 (0-45) 0 (0-0) 1.00
SPT wheal diameter (mm), median (IQR)
Negative control 0 (0-0) 0 (0-0) 1.00 0 (0-0) 0 (0-0) 1.00
Histamine (positive control) 5 (5-5) 5 (5-5) 1.00 5 (5-5) 5 (5-5) 1.00
Birch pollen 0 (0-0) 5 (4-6) .004 4 (3.5-6) 5 (5-5.5) .60
Timothy grass pollen 0 (0-0) 0 (0-0) 1.00 0 (0-2.5) 0 (0-0) 1.00
Festuca pratensis pollen 0 (0-0) 0 (0-0) 1.00 0 (0-2.5) 0 (0-0) 1.00
Mugwort pollen 0 (0-0) 0 (0-0) 1.00 0 (0-2.5) 0 (0-0) 1.00
Cladosporium herbarum 0 (0-0) 0 (0-0) 1.00 0 (0-0) 0 (0-0) 1.00
Cat dander 0 (0-0) 0 (0-5) .46 0 (0-2.5) 0 (0-3) 1.00
Dog dander 0 (0-0) 0 (0-4) .46 0 (0-2) 0 (0-2.5) 1.00
Horse dander 0 (0-0) 0 (0-0) 1.00 0 (0-0) 0 (0-0) 1.00
Dermatophagoides pteronyssinus 0 (0-0) 0 (0-0) 1.00 0 (0-0) 0 (0-0) 1.00
316
Diagnosis of allergic rhinitis (AR) was based on a typical history, skin prick test (SPT; ALK-Abello, 317
Hørsholm, Denmark), total serum IgE, and serum birch and timothy allergen specific IgE antibodies. 318
Healthy volunteers did not have symptoms and were negative for SPT of common aeroallergens and 319 serum birch and timothy allergen specific IgE antibodies. Exclusion criteria were: age under 12 years, 320 use of tobacco products, nonallergic rhinitis, allergic rhinitis symptoms caused by other than seasonal 321 allergens, asthma, and general disease requiring regular medication. Asthma was excluded by absence 322 of typical symptoms and by normal values in spirometry with bronchodilation test. 1) One subject 323 starting pollen allergen immunotherapy (AIT) was tested for bronchial hyperresponsiveness by were hierarchically clustered using average linkage and distance metric Pearson correlation. Acronym 397 S1 in the sample name stands for first spring (May), S2 for the second spring, W1 for the first winter 398 (November), and W2 for the second winter. Comparisons that reached the statistical significance are 399 indicated by black boxes next to the heatmap. A C C E P T E D ACCEPTED MANUSCRIPT S1_10 S1_6 S1_7 S1_9 S1_11 S1_8
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